Corrigendum to `P-Glycoprotein activation by 1-(propan-2-ylamino)-4-propoxy-9H-thioxanthen-9-one (TX5) in rat distal ileum: Ex vivo and in vivo studies¿ [Toxicology and Applied Pharmacology 386 (2020) 114832]

• Type: Other Publications
• Date: 2020

Authors

Rocha-Pereira, C (Author) Other; Ghanem, CI (Author) Other; Silva, R (Author) Other; Casanova, AG (Author) Other; Margarida Araújo (Author) ICBAS; Gonçalves-Monteiro, S (Author) Other; Sousa, E (Author) Other; de Lourdes Bastos, M (Author) Other; Fernando Remiao (Author) FFUP

Other information

Authenticus ID: P-00V-738

DOI: 10.1016/j.taap.2020.115168

Abstract (EN): The authors regret. The authors realized that the online version of the paper presents a small error in Fig. 4. Particularly, the graph distinguishes 4 different lines, referring to the control (DMSO), treatment with TX5 (TX5 20 uM), control in the presence of verapamil (DMSO + VER 100 uM) and TX5 in the presence of verapamil (TX5 20 uM + VER 100 uM). However, this distinction is not made in the legend, where repeated lines appear, not differentiating the treatments (dashed lines do not appear). The authors believe that this was a printing error since the figure is correct in the version of the article submitted for publication after proofreading. Thus, the authors cordially request the correction of the figure in accordance with what has been above described. For better understanding, the authors copy the figure here again as it should appear in the corrected version of the article (green text and arrow to localize the error!). The authors would like to apologise for any inconvenience caused. DOI of original article: doi: https://doi.org/10.1016/j.taap.2019.114832 © 2019 Elsevier Inc.

Language: English

Type (Professor's evaluation): Scientific